These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. An etiologic approach to management of duodenal and gastric ulcers. Rex DK J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053 [TBL] [Abstract][Full Text] [Related]
65. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders]. De Natale G; De Natale F; Marino A Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647 [TBL] [Abstract][Full Text] [Related]
66. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists. Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457 [TBL] [Abstract][Full Text] [Related]
67. [Drug therapy of peptic ulcer in the elderly]. Koop H Z Gerontol; 1992; 25(5):304-8. PubMed ID: 1359717 [TBL] [Abstract][Full Text] [Related]
68. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate. Marks IN; Lucke W; Wright JP; Girdwood AH J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353 [TBL] [Abstract][Full Text] [Related]
69. Pirenzepine in the treatment of peptic ulcer disease. Review and commentary. Bianchi Porro G; Petrillo M Scand J Gastroenterol Suppl; 1982; 72():229-36. PubMed ID: 6753117 [TBL] [Abstract][Full Text] [Related]
70. Anti-ulcer therapy. Past to present. Bettarello A Dig Dis Sci; 1985 Nov; 30(11 Suppl):36S-42S. PubMed ID: 2865091 [TBL] [Abstract][Full Text] [Related]
71. Lansoprazole: a comprehensive review. Zimmermann AE; Katona BG Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323 [TBL] [Abstract][Full Text] [Related]
72. The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy. Jones DB; Hunt RH Aust N Z J Med; 1986 Apr; 16(2):263-7. PubMed ID: 2875708 [No Abstract] [Full Text] [Related]
73. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding? Geus WP Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484 [TBL] [Abstract][Full Text] [Related]
74. [Cimetidine versus antacids]. Halter F Schweiz Med Wochenschr; 1979 Apr; 109(14):497-502. PubMed ID: 432582 [TBL] [Abstract][Full Text] [Related]
75. Health and economic aspects of peptic ulcer disease. Jensen DM Am J Med; 1984 Nov; 77(5B):8-14. PubMed ID: 6150640 [TBL] [Abstract][Full Text] [Related]
76. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori? Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465 [TBL] [Abstract][Full Text] [Related]
77. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer. Florent C Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399 [TBL] [Abstract][Full Text] [Related]
78. A comparison of cimetidine and sucralfate in the treatment of bleeding peptic ulcers. Goldfarb JP; Czaja MJ Am J Gastroenterol; 1985 Jan; 80(1):5-7. PubMed ID: 3881014 [TBL] [Abstract][Full Text] [Related]